Home / Learn / Precision Medicine / Immunotherapy / Policy & Reimbursement

Policy & Reimbursement

From Oncology Issues

The Latest Resource

FROM THE ACCCBUZZ BLOG

  • Expanding Access to Bispecific Antibodies in Community Cancer Care
    August 03, 2022
    Learn how ACCC's bispecific antibody initiative “Best Practices in Expanding Access to Bispecific Antibodies and Adverse Event Management”—developed in partnership with the Society for Immunotherapy of Cancer—will help expand the use of these novel therapies and optimize care for patients with cancer.
  • Micro Inmunoterapia_ACCCBuzz
    ACCC Tools for Immuno-Oncology Survivorship Care
    June 03, 2022
    In recognizing Cancer Immunotherapy Month and National Cancer Survivors Day (June 5), ACCC is highlighting the resources it has created to assist the multidisciplinary team in creating and adapting survivorship care plans to meet these patients’ unique needs and support toxicity management for better outcomes.
  • BEST OF 2020 WEB PAGE
    The Best (and Worst) of 2020
    December 30, 2020
  • Sigrun Hallmeyer pic
    June Is Cancer Immunotherapy Month
    June 25, 2020
    In recognition of Cancer Immunotherapy Month, ACCCBuzz talked to Sigrun Hallmeyer, MD, the chair of the ACCC Immuno-Oncology Institute’s Executive Committee.